Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
In the comprehensive preclinical studies, MDR-001 has demonstrated excellent functional potency and selectivity, with favorable ADME properties and oral bioavailability, as well as desirable pharmacokinetics and tolerability
Both drugs commonly cause nausea, vomiting, and diarrhea
Long-term safety and optimal treatment duration remain uncertain, necessitating cautious, multidisciplinary management
While findings are encouraging, more long-term, large-scale clinical trials are needed to determine its safety, efficacy, and the durability of its effects after treatment ends
Third-Party Testing: Look for labels confirming potency and purity testing by an independent lab
US$ 20.96
US$ 21.03
US$ 21.84
US$ 26.08
US$ 27.31
US$ 22.40
US$ 29.36
